Advertisements



Divi"s stock: Pricing pressure for drug makers can lead to more outsourcing

Analysts at Motilal Oswal Securities expect Divi's earnings before interest, tax, depreciation and amortisation (Ebitda) margin to improve by 400 basis points to 36 per cent.....»»

Category: topSource: business-standardApr 16th, 2018

Mylan stock drops 3% after wipeout of a second quarter

Chief Executive Heather Bresch, who became the poster child for pharmaceutical villainy over EpiPen price hikes in 2016, also critiqued the U.S. drug pricing system......»»

Category: topSource: moneycentralAug 8th, 2018

Mylan stock drops 3% after wipeout of a second quarter

Chief Executive Heather Bresch, who became the poster child for pharmaceutical villainy over EpiPen price hikes in 2016, also critiqued the U.S. drug pricing system......»»

Category: topSource: marketwatchAug 8th, 2018

AbbVie"s Stock Hit By Citron Tweet

In a speech on Wednesday, U.S. Food and Drug Administration commissioner Scott Gottlieb ripped drug makers for blocking competitors from bringing potentially cheaper biosimilar drugs to the market. read more.....»»

Category: blogSource: benzingaJul 19th, 2018

Altria: New Products and Improved Structure Could Lead to a Successful Turnaround

The outlook for Altria may be significantly more positive than the stock market is pricing inRelated Stocks: MO,.....»»

Category: blogSource: gurufocusJun 25th, 2018

FDA Shame List: 40 Drug Makers That Try to Block Generic Drugs

InvestorPlace - Stock Market News, Stock Advice & Trading T.....»»

Category: topSource: investorplaceMay 19th, 2018

Infinera stock falls after company warns of pricing pressure, but analysts maintain bullish stances

Shares of Infinera Corp. are down 8.2% in premarket trading Thursday after the optical transmission equipment maker reported better-than-expected quarterly results but spoke of pricing pressure fr.....»»

Category: topSource: marketwatchMay 10th, 2018

Generic drug makers under pressure following Aceto, Novartis news

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 19th, 2018

Teva under pressure as Express Scripts snubs new migraine drug, covers rivals

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall36 min. ago

Akorn Upgraded By Piper Jaffray On Improved Cost Structure, Product Potential

A closer look at Akorn, Inc. (NASDAQ: AKRX)'s generics business led Piper Jaffray to turn bullish on the drug manufacturer's stock.  Latest Ra.....»»

Category: blogSource: benzinga3 hr. 6 min. ago

Johnson & Johnson says pricing pressure impacted all Ortho divisions

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 16th, 2018

Data Sheet—Fortune Global Forum Talks China, Drug Pricing, and Nobel Winners

This is your Data Sheet newsletter for Tuesday, Octo.....»»

Category: europeSource: fortuneOct 16th, 2018

Drug Companies To Disclose Pricing Information In Ads

When anger over EpiPen pricing erupted in 2016, generic drugmaker Mylan NV (NASDAQ: MYL) was villainized.  The price of the autoinjector used for severe allergic reactions was hiked by about 500 percent between 2007 and 2016.  read more.....»»

Category: blogSource: benzingaOct 15th, 2018

Tiffany: Short-Term Pain Could Lead to Long-Term Stock Price Gains

The company’s investment strategy could create a stronger businessRelated Stocks: TIF,.....»»

Category: worldSource: nytOct 15th, 2018

China polysilicon makers start production at new plants

Some China-based polysilicon makers have started production at new plants established in regions offering lower production costs, which is expected to send product pricing further declining amid weak demand, according to industry sources......»»

Category: topSource: digitimesOct 15th, 2018

Pressure set to resume for Wall Street as stock futures pitch lower - MarketWatch

MarketWatchPressur.....»»

Category: topSource: googlenewsOct 15th, 2018

Market Snapshot: Pressure set to resume for Wall Street as stock futures pitch lower

U.S. stock futures trade sharply lower early Monday as a rebound from late last week sputters out in Asia. Retail sales and earnings from Bank of America and Charles Schwab are on tap......»»

Category: topSource: marketwatchOct 15th, 2018

Trump Signs 2 Drug Pricing Bills, HHS Secretary Promises ‘More to Come’

The bills do away with pharmacy "gag" clauses. On Wednesday, President Donald Trump signed .....»»

Category: europeSource: fortuneOct 11th, 2018

US Market Indexes Continue Losses, S&P 500 Down -2.06% Thursday

Energy, financial and real estate lead lossesCheck out Chase Coleman Stock Picks » Download GuruFolio Report of Chase Coleman (Updated on 10/10/2018)Related Stocks: GE, PFE, XOM,.....»»

Category: dealsSource: nytOct 11th, 2018

Dow drops over 500 points, with stock market extending slide following Wednesday's plunge

The stock market -- after its worst slide in eight months -- remains under pressure Thursday as investors weigh risks of higher interest rat.....»»

Category: topSource: usatodayOct 11th, 2018

Call "em crazy, but Fed officials likely to keep raising rates

A stock sell-off, rising trade tension with China, slower global growth and verbal pressure from the White House are unlikely to dent the U.S. Federal Reserve's rate hike plans in an economy performing in line with the central bank's forecasts......»»

Category: topSource: reutersOct 11th, 2018